Advanced search
Publication Cover
Bioengineered Volume 10, 2019 - Issue 1
Submit an article Journal homepage
2,311
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Vaccinia virus injected human tumors: oncolytic virus efficiency predicted by antigen profiling analysis fitted boolean models

Alexander Cecila Department of Biochemistry, Theodor-Boveri-Institute, University of Würzburg, Biocenter, Würzburg, Germany;b Department of Bioinformatics, Theodor-Boveri-Institute, University of Würzburg, Biocenter, Würzburg, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1430-1790View further author information
ORCID Icon,
Ivaylo Gentscheva Department of Biochemistry, Theodor-Boveri-Institute, University of Würzburg, Biocenter, Würzburg, Germany;c Genelux Corporation, San Diego, CA, USACorrespondence[email protected]
View further author information
,
Marion Adelfingera Department of Biochemistry, Theodor-Boveri-Institute, University of Würzburg, Biocenter, Würzburg, GermanyView further author information
,
Thomas Dandekarb Department of Bioinformatics, Theodor-Boveri-Institute, University of Würzburg, Biocenter, Würzburg, GermanyView further author information
&
Aladar A. Szalaya Department of Biochemistry, Theodor-Boveri-Institute, University of Würzburg, Biocenter, Würzburg, Germany;d Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California, San Diego, CA, USACorrespondence[email protected]
View further author information
Pages 190-196 | Received 05 Nov 2018, Accepted 14 May 2019, Published online: 29 May 2019

References

  • Guo ZS, Lu B, Guo Z, et al. Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics. J Immunother Cancer. 2019;7:6.
  • Warner SG, O’Leary MP, Fong Y. Therapeutic oncolytic viruses: clinical advances and future directions. Curr Opin Oncol. 2017;29:359–365.
  • Lichty BD, Breitbach CJ, Stojdl DF, et al. Going viral with cancer immunotherapy. Nat Rev Cancer. 2014;14:559–567.
  • Garber K. China approves world’s first oncolytic virus therapy for cancer treatment. J Natl Cancer Inst. 2006;98:298–300.
  • Zhang Q, Yu YA, Wang E, et al. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Cancer Res. 2007;67:10038–10046.
  • Yu YA, Galanis C, Woo Y, et al. Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68. Mol Cancer Ther. 2009;8:141–151.
  • Yu Z, Li S, Brader P, et al. Oncolytic vaccinia therapy of squamous cell carcinoma. Mol Cancer. 2009;8:45.
  • Cecil A, Gentschev I, Adelfinger M, et al. Antigen profiling analysis of vaccinia virus injected canine tumors: oncolytic virus efficiency predicted by boolean models. Bioengineered. 2014;5:319–325.
  • Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30.
  • Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet. 2016;387:70–82.
  • Gentschev I, Muller M, Adelfinger M, et al. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. PLoS One. 2011;6:e22069.
  • Gentschev I, Donat U, Hofmann E, et al. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68. J Biomed Biotechnol. 2010;2010:489759.
  • Donat U, Weibel S, Hess M, et al. Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice. PLoS One. 2012;7:e45942.
  • Hofmann E, Weibel S, Szalay AA. Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice. J Transl Med. 2014;12:197.
  • Fridlender ZG, Sun J, Kim S, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell. 2009;16:183–194.
  • Moehler MH, Zeidler M, Wilsberg V, et al. Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis, maturation, and cross-presentation by dendritic cells. Hum Gene Ther. 2005;16:996–1005.
  • Funahashi A, Matsuoka Y, Jouraku A, et al. CellDesigner3.5: a versatile modeling tool for biochemical networks. Proc IEEE. 2008;96(8):1254–1265.
  • yWorks. (2014). yED. https://www.yworks.com/downloads#yEd
  • Di Cara A, Garg A, De Micheli G, et al. Dynamic simulation of regulatory networks using SQUAD. BMC Bioinformatics. 2007;8:462.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.